Report Detail

Chemical & Material Global Bio-based Pentylenediamine Market Research Report 2021

  • RnM4313111
  • |
  • 22 April, 2021
  • |
  • Global
  • |
  • 129 Pages
  • |
  • QYResearch
  • |
  • Chemical & Material

1 Bio-based Pentylenediamine Market Overview

  • 1.1 Product Overview and Scope of Bio-based Pentylenediamine
  • 1.2 Bio-based Pentylenediamine Segment by Type
    • 1.2.1 Global Bio-based Pentylenediamine Market Size Growth Rate Analysis by Type 2021 VS 2027
    • 1.2.2 Polyamide
    • 1.2.3 PDI
    • 1.2.4 Epoxy Curing Agent
    • 1.2.5 Organic Synthesis Intermediate
    • 1.2.6 Others
  • 1.3 Bio-based Pentylenediamine Segment by Application
    • 1.3.1 Global Bio-based Pentylenediamine Consumption Comparison by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Spinning
    • 1.3.3 Engineering Materials
    • 1.3.4 Medicine
    • 1.3.5 Pesticides
    • 1.3.6 Organic Synthesis
    • 1.3.7 Others
  • 1.4 Global Market Growth Prospects
    • 1.4.1 Global Bio-based Pentylenediamine Revenue Estimates and Forecasts (2016-2027)
    • 1.4.2 Global Bio-based Pentylenediamine Production Capacity Estimates and Forecasts (2016-2027)
    • 1.4.3 Global Bio-based Pentylenediamine Production Estimates and Forecasts (2016-2027)
  • 1.5 Global Market Size by Region
    • 1.5.1 Global Bio-based Pentylenediamine Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
    • 1.5.2 North America Bio-based Pentylenediamine Estimates and Forecasts (2016-2027)
    • 1.5.3 Europe Bio-based Pentylenediamine Estimates and Forecasts (2016-2027)
    • 1.5.4 China Bio-based Pentylenediamine Estimates and Forecasts (2016-2027)
    • 1.5.5 Japan Bio-based Pentylenediamine Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

  • 2.1 Global Bio-based Pentylenediamine Production Capacity Market Share by Manufacturers (2016-2021)
  • 2.2 Global Bio-based Pentylenediamine Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Bio-based Pentylenediamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.4 Global Bio-based Pentylenediamine Average Price by Manufacturers (2016-2021)
  • 2.5 Manufacturers Bio-based Pentylenediamine Production Sites, Area Served, Product Types
  • 2.6 Bio-based Pentylenediamine Market Competitive Situation and Trends
    • 2.6.1 Bio-based Pentylenediamine Market Concentration Rate
    • 2.6.2 Global 5 and 10 Largest Bio-based Pentylenediamine Players Market Share by Revenue
    • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

  • 3.1 Global Production Capacity of Bio-based Pentylenediamine Market Share by Region (2016-2021)
  • 3.2 Global Bio-based Pentylenediamine Revenue Market Share by Region (2016-2021)
  • 3.3 Global Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.4 North America Bio-based Pentylenediamine Production
    • 3.4.1 North America Bio-based Pentylenediamine Production Growth Rate (2016-2021)
    • 3.4.2 North America Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.5 Europe Bio-based Pentylenediamine Production
    • 3.5.1 Europe Bio-based Pentylenediamine Production Growth Rate (2016-2021)
    • 3.5.2 Europe Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.6 China Bio-based Pentylenediamine Production
    • 3.6.1 China Bio-based Pentylenediamine Production Growth Rate (2016-2021)
    • 3.6.2 China Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.7 Japan Bio-based Pentylenediamine Production
    • 3.7.1 Japan Bio-based Pentylenediamine Production Growth Rate (2016-2021)
    • 3.7.2 Japan Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Bio-based Pentylenediamine Consumption by Region

  • 4.1 Global Bio-based Pentylenediamine Consumption by Region
    • 4.1.1 Global Bio-based Pentylenediamine Consumption by Region
    • 4.1.2 Global Bio-based Pentylenediamine Consumption Market Share by Region
  • 4.2 North America
    • 4.2.1 North America Bio-based Pentylenediamine Consumption by Country
    • 4.2.2 United States
    • 4.2.3 Canada
  • 4.3 Europe
    • 4.3.1 Europe Bio-based Pentylenediamine Consumption by Country
    • 4.3.2 Germany
    • 4.3.3 France
    • 4.3.4 U.K.
    • 4.3.5 Italy
    • 4.3.6 Russia
  • 4.4 Asia Pacific
    • 4.4.1 Asia Pacific Bio-based Pentylenediamine Consumption by Region
    • 4.4.2 China
    • 4.4.3 Japan
    • 4.4.4 South Korea
    • 4.4.5 Taiwan
    • 4.4.6 Southeast Asia
    • 4.4.7 India
    • 4.4.8 Australia
  • 4.5 Latin America
    • 4.5.1 Latin America Bio-based Pentylenediamine Consumption by Country
    • 4.5.2 Mexico
    • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

  • 5.1 Global Bio-based Pentylenediamine Production Market Share by Type (2016-2021)
  • 5.2 Global Bio-based Pentylenediamine Revenue Market Share by Type (2016-2021)
  • 5.3 Global Bio-based Pentylenediamine Price by Type (2016-2021)

6 Consumption Analysis by Application

  • 6.1 Global Bio-based Pentylenediamine Consumption Market Share by Application (2016-2021)
  • 6.2 Global Bio-based Pentylenediamine Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

  • 7.1 Cathay Biotech Inc.
    • 7.1.1 Cathay Biotech Inc. Bio-based Pentylenediamine Corporation Information
    • 7.1.2 Cathay Biotech Inc. Bio-based Pentylenediamine Product Portfolio
    • 7.1.3 Cathay Biotech Inc. Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.1.4 Cathay Biotech Inc. Main Business and Markets Served
    • 7.1.5 Cathay Biotech Inc. Recent Developments/Updates
  • 7.2 Aphena Pharma Solutions
    • 7.2.1 Aphena Pharma Solutions Bio-based Pentylenediamine Corporation Information
    • 7.2.2 Aphena Pharma Solutions Bio-based Pentylenediamine Product Portfolio
    • 7.2.3 Aphena Pharma Solutions Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.2.4 Aphena Pharma Solutions Main Business and Markets Served
    • 7.2.5 Aphena Pharma Solutions Recent Developments/Updates
  • 7.3 Bio-Tech Pharmacal
    • 7.3.1 Bio-Tech Pharmacal Bio-based Pentylenediamine Corporation Information
    • 7.3.2 Bio-Tech Pharmacal Bio-based Pentylenediamine Product Portfolio
    • 7.3.3 Bio-Tech Pharmacal Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.3.4 Bio-Tech Pharmacal Main Business and Markets Served
    • 7.3.5 Bio-Tech Pharmacal Recent Developments/Updates
  • 7.4 Goodwin Biotechnology
    • 7.4.1 Goodwin Biotechnology Bio-based Pentylenediamine Corporation Information
    • 7.4.2 Goodwin Biotechnology Bio-based Pentylenediamine Product Portfolio
    • 7.4.3 Goodwin Biotechnology Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.4.4 Goodwin Biotechnology Main Business and Markets Served
    • 7.4.5 Goodwin Biotechnology Recent Developments/Updates
  • 7.5 Xenon Pharmaceuticals
    • 7.5.1 Xenon Pharmaceuticals Bio-based Pentylenediamine Corporation Information
    • 7.5.2 Xenon Pharmaceuticals Bio-based Pentylenediamine Product Portfolio
    • 7.5.3 Xenon Pharmaceuticals Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.5.4 Xenon Pharmaceuticals Main Business and Markets Served
    • 7.5.5 Xenon Pharmaceuticals Recent Developments/Updates
  • 7.6 Nektar Therapeutics
    • 7.6.1 Nektar Therapeutics Bio-based Pentylenediamine Corporation Information
    • 7.6.2 Nektar Therapeutics Bio-based Pentylenediamine Product Portfolio
    • 7.6.3 Nektar Therapeutics Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.6.4 Nektar Therapeutics Main Business and Markets Served
    • 7.6.5 Nektar Therapeutics Recent Developments/Updates
  • 7.7 Midas Pharmaceuticals
    • 7.7.1 Midas Pharmaceuticals Bio-based Pentylenediamine Corporation Information
    • 7.7.2 Midas Pharmaceuticals Bio-based Pentylenediamine Product Portfolio
    • 7.7.3 Midas Pharmaceuticals Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.7.4 Midas Pharmaceuticals Main Business and Markets Served
    • 7.7.5 Midas Pharmaceuticals Recent Developments/Updates
  • 7.8 Kedrion Biopharma
    • 7.8.1 Kedrion Biopharma Bio-based Pentylenediamine Corporation Information
    • 7.8.2 Kedrion Biopharma Bio-based Pentylenediamine Product Portfolio
    • 7.8.3 Kedrion Biopharma Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.8.4 Kedrion Biopharma Main Business and Markets Served
    • 7.7.5 Kedrion Biopharma Recent Developments/Updates
  • 7.9 Xcelthera
    • 7.9.1 Xcelthera Bio-based Pentylenediamine Corporation Information
    • 7.9.2 Xcelthera Bio-based Pentylenediamine Product Portfolio
    • 7.9.3 Xcelthera Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.9.4 Xcelthera Main Business and Markets Served
    • 7.9.5 Xcelthera Recent Developments/Updates
  • 7.10 Anichem
    • 7.10.1 Anichem Bio-based Pentylenediamine Corporation Information
    • 7.10.2 Anichem Bio-based Pentylenediamine Product Portfolio
    • 7.10.3 Anichem Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.10.4 Anichem Main Business and Markets Served
    • 7.10.5 Anichem Recent Developments/Updates
  • 7.11 ALC Bio Innovations
    • 7.11.1 ALC Bio Innovations Bio-based Pentylenediamine Corporation Information
    • 7.11.2 ALC Bio Innovations Bio-based Pentylenediamine Product Portfolio
    • 7.11.3 ALC Bio Innovations Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.11.4 ALC Bio Innovations Main Business and Markets Served
    • 7.11.5 ALC Bio Innovations Recent Developments/Updates
  • 7.12 ACADIA Pharmaceuticals
    • 7.12.1 ACADIA Pharmaceuticals Bio-based Pentylenediamine Corporation Information
    • 7.12.2 ACADIA Pharmaceuticals Bio-based Pentylenediamine Product Portfolio
    • 7.12.3 ACADIA Pharmaceuticals Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.12.4 ACADIA Pharmaceuticals Main Business and Markets Served
    • 7.12.5 ACADIA Pharmaceuticals Recent Developments/Updates
  • 7.13 AbbVie Inc.
    • 7.13.1 AbbVie Inc. Bio-based Pentylenediamine Corporation Information
    • 7.13.2 AbbVie Inc. Bio-based Pentylenediamine Product Portfolio
    • 7.13.3 AbbVie Inc. Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.13.4 AbbVie Inc. Main Business and Markets Served
    • 7.13.5 AbbVie Inc. Recent Developments/Updates
  • 7.14 Ology Bioservices
    • 7.14.1 Ology Bioservices Bio-based Pentylenediamine Corporation Information
    • 7.14.2 Ology Bioservices Bio-based Pentylenediamine Product Portfolio
    • 7.14.3 Ology Bioservices Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.14.4 Ology Bioservices Main Business and Markets Served
    • 7.14.5 Ology Bioservices Recent Developments/Updates
  • 7.15 QMI - Quality Management
    • 7.15.1 QMI - Quality Management Bio-based Pentylenediamine Corporation Information
    • 7.15.2 QMI - Quality Management Bio-based Pentylenediamine Product Portfolio
    • 7.15.3 QMI - Quality Management Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.15.4 QMI - Quality Management Main Business and Markets Served
    • 7.15.5 QMI - Quality Management Recent Developments/Updates
  • 7.16 Biomiga
    • 7.16.1 Biomiga Bio-based Pentylenediamine Corporation Information
    • 7.16.2 Biomiga Bio-based Pentylenediamine Product Portfolio
    • 7.16.3 Biomiga Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.16.4 Biomiga Main Business and Markets Served
    • 7.16.5 Biomiga Recent Developments/Updates
  • 7.17 Molecular Targeting Technologies
    • 7.17.1 Molecular Targeting Technologies Bio-based Pentylenediamine Corporation Information
    • 7.17.2 Molecular Targeting Technologies Bio-based Pentylenediamine Product Portfolio
    • 7.17.3 Molecular Targeting Technologies Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.17.4 Molecular Targeting Technologies Main Business and Markets Served
    • 7.17.5 Molecular Targeting Technologies Recent Developments/Updates

8 Bio-based Pentylenediamine Manufacturing Cost Analysis

  • 8.1 Bio-based Pentylenediamine Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Raw Materials Price Trend
    • 8.1.3 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Bio-based Pentylenediamine
  • 8.4 Bio-based Pentylenediamine Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Bio-based Pentylenediamine Distributors List
  • 9.3 Bio-based Pentylenediamine Customers

10 Market Dynamics

  • 10.1 Bio-based Pentylenediamine Industry Trends
  • 10.2 Bio-based Pentylenediamine Growth Drivers
  • 10.3 Bio-based Pentylenediamine Market Challenges
  • 10.4 Bio-based Pentylenediamine Market Restraints

11 Production and Supply Forecast

  • 11.1 Global Forecasted Production of Bio-based Pentylenediamine by Region (2022-2027)
  • 11.2 North America Bio-based Pentylenediamine Production, Revenue Forecast (2022-2027)
  • 11.3 Europe Bio-based Pentylenediamine Production, Revenue Forecast (2022-2027)
  • 11.4 China Bio-based Pentylenediamine Production, Revenue Forecast (2022-2027)
  • 11.5 Japan Bio-based Pentylenediamine Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

  • 12.1 Global Forecasted Demand Analysis of Bio-based Pentylenediamine
  • 12.2 North America Forecasted Consumption of Bio-based Pentylenediamine by Country
  • 12.3 Europe Market Forecasted Consumption of Bio-based Pentylenediamine by Country
  • 12.4 Asia Pacific Market Forecasted Consumption of Bio-based Pentylenediamine by Region
  • 12.5 Latin America Forecasted Consumption of Bio-based Pentylenediamine by Country

13 Forecast by Type and by Application (2022-2027)

  • 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
    • 13.1.1 Global Forecasted Production of Bio-based Pentylenediamine by Type (2022-2027)
    • 13.1.2 Global Forecasted Revenue of Bio-based Pentylenediamine by Type (2022-2027)
    • 13.1.3 Global Forecasted Price of Bio-based Pentylenediamine by Type (2022-2027)
  • 13.2 Global Forecasted Consumption of Bio-based Pentylenediamine by Application (2022-2027)

14 Research Finding and Conclusion

    15 Methodology and Data Source

    • 15.1 Methodology/Research Approach
      • 15.1.1 Research Programs/Design
      • 15.1.2 Market Size Estimation
      • 15.1.3 Market Breakdown and Data Triangulation
    • 15.2 Data Source
      • 15.2.1 Secondary Sources
      • 15.2.2 Primary Sources
    • 15.3 Author List

    The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Polyamide
    PDI
    Epoxy Curing Agent
    Organic Synthesis Intermediate
    Others

    Segment by Application
    Spinning
    Engineering Materials
    Medicine
    Pesticides
    Organic Synthesis
    Others

    By Company
    Cathay Biotech Inc.
    Aphena Pharma Solutions
    Bio-Tech Pharmacal
    Goodwin Biotechnology
    Xenon Pharmaceuticals
    Nektar Therapeutics
    Midas Pharmaceuticals
    Kedrion Biopharma
    Xcelthera
    Anichem
    ALC Bio Innovations
    ACADIA Pharmaceuticals
    AbbVie Inc.
    Ology Bioservices
    QMI - Quality Management
    Biomiga
    Molecular Targeting Technologies

    Production by Region
    North America
    Europe
    China
    Japan

    Consumption by Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    China Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE


    Summary:
    Get latest Market Research Reports on Bio-based Pentylenediamine. Industry analysis & Market Report on Bio-based Pentylenediamine is a syndicated market report, published as Global Bio-based Pentylenediamine Market Research Report 2021. It is complete Research Study and Industry Analysis of Bio-based Pentylenediamine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,059.00
    3,088.50
    4,118.00
    2,389.60
    3,584.40
    4,779.20
    317,231.00
    475,846.50
    634,462.00
    212,686.00
    319,029.00
    425,372.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report